We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

15 hedge funds and large institutions have $26.6M invested in GW Pharmaceuticals Plc American Depositary Shares in 2013 Q2 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VM
1
VHCP Management
New York
$7.38M +$7.42M +837,800 New
PP
2
Prudential plc
United Kingdom
$5.34M +$5.45M +615,000 New
FCM
3
Farallon Capital Management
California
$4.93M +$4.96M +560,000 New
PHS
4
PFM Health Sciences
California
$3.41M +$3.43M +386,844 New
BC
5
Broadfin Capital
New York
$2.47M +$2.48M +280,000 New
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$1.26M +$1.28M +145,130 New
A
7
Abingworth
United Kingdom
$879K +$905K +102,200 New
CA
8
Commerzbank Aktiengesellschaft
Germany
$441K +$443K +50,045 New
UOC
9
UBS O'Connor
Illinois
$304K +$310K +35,060 New
PIM
10
Partner Investment Management
California
$116K +$116K +13,156 New
JRJ
11
Jeffrey R. Jay
$102K +$103K +11,622 New
TRCT
12
Tower Research Capital (TRC)
New York
$6K +$6.21K +702 New
AIG
13
American International Group
New York
$1.73K +$1.74K +196 New
Bank of Montreal
14
Bank of Montreal
Ontario, Canada
$1K +$885 +100 New
U
15
UBS
Switzerland
$1K +$1.18K +133 New

GWPH Hedge Fund Activity: Q2 2013 in Review

15 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2013, worth a combined $26.6M.

Buyers outnumbered sellers: 15 funds opened new GWPH positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

  • 15 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $26.6M of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2013.
  • 15 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2013 and 0 closed out, a net change of +15 holders.

Based on aggregated 13F filings for Q2 2013.